| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gossamer Bio, Inc. | COO/CFO | Common Stock | 480 K | $284 K | $0.59 | Jun 18, 2024 | By family trust |
| Gossamer Bio, Inc. | COO/CFO | Stock Option (Right to Buy) | 544 K | Jan 2, 2024 | Direct | ||
| Protagonist Therapeutics, Inc | Director | Stock Option (right to buy) | 25.7 K | Jan 2, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio, Inc. | Jun 18, 2024 | 1 | $59.1 K | 4 | Jun 20, 2024 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | Mar 27, 2024 | 1 | -$7.43 K | 4 | Mar 28, 2024 | COO/CFO |
| PTGX | Protagonist Therapeutics, Inc | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
| GOSS | Gossamer Bio, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | Nov 20, 2023 | 1 | $0 | 4 | Nov 22, 2023 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | Nov 13, 2023 | 1 | $113 K | 4 | Nov 14, 2023 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | Jul 24, 2023 | 2 | $100 K | 4 | Jul 26, 2023 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | May 5, 2023 | 10 | $0 | 4 | May 9, 2023 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | Apr 4, 2023 | 1 | $56.1 K | 4 | Apr 5, 2023 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | Mar 20, 2023 | 2 | $48.4 K | 4 | Mar 22, 2023 | COO/CFO |
| PTGX | Protagonist Therapeutics, Inc | Jan 16, 2023 | 1 | $0 | 4 | Jan 18, 2023 | Director |
| GOSS | Gossamer Bio, Inc. | Dec 7, 2022 | 1 | $0 | 4 | Dec 9, 2022 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | Jul 15, 2022 | 1 | $100 K | 4 | Jul 15, 2022 | COO/CFO |
| PTGX | Protagonist Therapeutics, Inc | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| GOSS | Gossamer Bio, Inc. | Mar 23, 2022 | 1 | -$95.6 K | 4 | Mar 24, 2022 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | Jan 6, 2022 | 1 | $0 | 4 | Jan 10, 2022 | COO/CFO |
| GOSS | Gossamer Bio, Inc. | Sep 16, 2021 | 1 | $0 | 4 | Sep 20, 2021 | COO/CFO |
| PTGX | Protagonist Therapeutics, Inc | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |